Literature DB >> 25934842

A novel semi-automated in situ hybridisation protocol for microRNA detection in paraffin embedded tissue sections.

Ambra Vittoria Gualeni1, Chiara Costanza Volpi1, Antonino Carbone2, Annunziata Gloghini1.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that modulate gene expression by binding to complementary sequences on target messenger RNA transcripts. In situ hybridisation (ISH) methods have been applied to the study of miRNA in tissue samples in order to understand which is the source of the miRNA of interest. In this paper, the authors describe a novel semi-automated bright field ISH method to visualise miRNAs in formalin fixed paraffin embedded tissue sections. The relevance of this work resides in the use of 3,3'-diaminobenzidine and peroxidase as the detection method, which provides a good defined deposition within tissues This method, which reveals the cells of origin of specific miRNAs, will enable investigators to further explore the biological role of miRNAs. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  IN SITU HYBRIDISATION; LYMPH NODES; LYMPHOMA; MOLECULAR PATHOLOGY

Mesh:

Substances:

Year:  2015        PMID: 25934842     DOI: 10.1136/jclinpath-2015-203005

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.

Authors:  Veronica Huber; Viviana Vallacchi; Viktor Fleming; Xiaoying Hu; Agata Cova; Matteo Dugo; Eriomina Shahaj; Roberta Sulsenti; Elisabetta Vergani; Paola Filipazzi; Angela De Laurentiis; Luca Lalli; Lorenza Di Guardo; Roberto Patuzzo; Barbara Vergani; Elena Casiraghi; Mara Cossa; Ambra Gualeni; Valentina Bollati; Flavio Arienti; Filippo De Braud; Luigi Mariani; Antonello Villa; Peter Altevogt; Viktor Umansky; Monica Rodolfo; Licia Rivoltini
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

2.  microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.

Authors:  Viviana Vallacchi; Chiara Camisaschi; Matteo Dugo; Elisabetta Vergani; Paola Deho; Ambra Gualeni; Veronica Huber; Annunziata Gloghini; Andrea Maurichi; Mario Santinami; Marialuisa Sensi; Chiara Castelli; Licia Rivoltini; Monica Rodolfo
Journal:  Genes (Basel)       Date:  2016-12-14       Impact factor: 4.096

3.  mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis.

Authors:  Cristina Borzi; Linda Calzolari; Giovanni Centonze; Massimo Milione; Gabriella Sozzi; Orazio Fortunato
Journal:  Int J Mol Sci       Date:  2017-01-23       Impact factor: 5.923

4.  New transcriptional-based insights into the pathogenesis of desmoplastic small round cell tumors (DSRCTs).

Authors:  Tiziana Negri; Silvia Brich; Fabio Bozzi; Chiara V Volpi; Ambra V Gualeni; Silvia Stacchiotti; Loris De Cecco; Silvana Canevari; Annunziata Gloghini; Silvana Pilotti
Journal:  Oncotarget       Date:  2017-05-16

5.  FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?

Authors:  Daniela Russo; Francesco Merolla; Massimo Mascolo; Gennaro Ilardi; Simona Romano; Silvia Varricchio; Virginia Napolitano; Angela Celetti; Loredana Postiglione; Pier Paolo Di Lorenzo; Luigi Califano; Giovanni Orabona Dell'Aversana; Fabio Astarita; Maria Fiammetta Romano; Stefania Staibano
Journal:  Int J Mol Sci       Date:  2017-02-18       Impact factor: 5.923

6.  Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk.

Authors:  Orazio Fortunato; Cristina Borzi; Massimo Milione; Giovanni Centonze; Davide Conte; Mattia Boeri; Carla Verri; Massimo Moro; Federica Facchinetti; Francesca Andriani; Luca Roz; Laura Caleca; Veronica Huber; Agata Cova; Chiara Camisaschi; Chiara Castelli; Valeria Cancila; Claudio Tripodo; Ugo Pastorino; Gabriella Sozzi
Journal:  Int J Cancer       Date:  2019-01-06       Impact factor: 7.396

7.  Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis.

Authors:  Mélanie A Cron; Solène Maillard; Frédérique Truffault; Ambra Vittoria Gualeni; Annunziata Gloghini; Elie Fadel; Julien Guihaire; Anthony Behin; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

8.  Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma.

Authors:  Antonino Belfiore; Adele Busico; Fabio Bozzi; Silvia Brich; Elena Dallera; Elena Conca; Iolanda Capone; Annunziata Gloghini; Chiara C Volpi; Antonello D Cabras; Silvana Pilotti; Dario Baratti; Marcello Guaglio; Marcello Deraco; Shigeki Kusamura; Federica Perrone
Journal:  Int J Mol Sci       Date:  2019-11-19       Impact factor: 5.923

9.  MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway.

Authors:  Massimo Moro; Orazio Fortunato; Giulia Bertolini; Mavis Mensah; Cristina Borzi; Giovanni Centonze; Francesca Andriani; Daniela Di Paolo; Patrizia Perri; Mirco Ponzoni; Ugo Pastorino; Gabriella Sozzi; Mattia Boeri
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.